[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367230-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367230-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","immunosenescence-promotes-cancer-development-from-mechanisms-to-treatment-strategies","Immunosenescence promotes cancer development: from mechanisms to treatment strategies","","The innate immune system is central to detecting and eliminating cancer cells, yet with age its function may deteriorate into dysfunctional, inefficient, or inactive states termed immunosenescence. This decline markedly increases malignancy risk. Although T-cell aging has been widely studied, effects on innate immune cells such as macrophages and neutrophils remain underexplored. This review addresses those gaps and links immunosenescence to the efficacy and safety of cancer immunotherapies, including ICIs.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/immunosenescence-promotes-cancer-development-from-mechanisms-to-treatment-strategies/367230/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/immunosenescence-promotes-cancer-development-from-mechanisms-to-treatment-strategies/367230.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is immunosenescence and why does it matter for cancer risk?","Question",{"text":63,"@type":64},"Immunosenescence describes age-related deterioration of immune function. This dysfunction reduces effective cancer cell elimination and increases the risk of malignancies.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which immune cell types does the review emphasize beyond T cells?",{"text":68,"@type":64},"The review focuses on innate immune cells, especially macrophages and neutrophils, whose responses to aging are described as insufficiently covered in prior literature.",{"name":70,"@type":61,"acceptedAnswer":71},"How does immunosenescence affect immune checkpoint inhibitor (ICI) outcomes in elderly patients?",{"text":72,"@type":64},"ICIs show broad potential across cancers, but elderly patients often benefit less and may experience immune-related adverse events (irAEs), which the review connects to immunosenescence.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367230,1791397200,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Wang and Tang Cell Communication and Signaling (2025) 23:128  \n[https://doi.org/10.1186/s12964-025-02082-6](https://doi.org/10.1186/s12964-025-02082-6)  \nCell Communication and Signaling  \nREVIEW Open Access  \nImmunosenescence promotes cancer  development: from mechanisms to treatment strategies  \nLeihan Wang 1 and Dong Tang2*  \nAbstract  \nThe body’s innate immune system plays a pivotal role in identifying and eliminating cancer cells. However, as the immune system ages, its functionality can deteriorate, becoming dysfunctional, inefficient, or even inactive—a condition referred to as immunosenescence. This decline significantly increases the risk of malignancies. While the pro-cancer effects ofT-cell aging have been widely explored, there remains a notable gap in the literature regarding the impact of aging on innate immune cells, such as macrophages and neutrophils. This review seeks to address this gap, with emphasis on these cell types. Furthermore, although certain cancer immunotherapies, including immune checkpoint inhibitors (ICIs), have demonstrated efficacy across a broad spectrum of cancers, elderly patients are less likely to derive clinical benefit from these treatments. In some cases, they may even experience immune-related adverse events (irAEs) . While senolytic strategies have shown promise in exerting anticancer effects, their adverse reactions and potential off-target effects present significant challenges. This review aims to elucidate the pro-cancer effects of immunosenescence, its implications for the efficacy and safety of ICIs, and potential anti-aging treatment strategies. In addition, optimizing anti-aging therapies to minimize adverse reactions and enhance therapeutic outcomes remains a critical focus for future research endeavors.  \nHighlights  \n• Senescence is an inevitable phenomenon in the human body, and scientists have explored the specific mechanisms by which immunosenescence advances the development of cancer.  \n• This review summarizes the mechanisms and characteristics of immunosenescence, which can be used as a level of surveillance for cancers due to immunosenescence.  \n• “Targeting immunosenescence” may be a new idea and strategy for cancer therapy.  \nKeywords Immunosenescence, Cancer, Senescence, Cancer therapy  \n*Correspondence: Dong Tang [83392785@qq.com](83392785@qq.com)  \n1Clinical Medical College, Yangzhou University, Yangzhou, People’s Republic of China  \n2Department of General Surgery, Institute of General Surgery, Northern Jiangsu People’s Hospital Affiliated to Yangzhou University; Northern Jiangsu People’s Hospital; The Yangzhou Clinical Medical College of Xuzhou Medical University; The Yangzhou School of Clinical Medicine of Dalian Medical University; The Yangzhou School of Clinical Medicine of Nanjing Medical University; Northern Jiangsu People’s Hospital, Clinical Teaching Hospital of Medical School, Nanjing University,  \nYangzhou 225000, China  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecomm","cbCaihRhYBm8fp98","https://ap.wps.com/l/cbCaihRhYBm8fp98","pdf",1905239,14,"English","# Abstract\n# Highlights\n# Keywords\n# Introduction\n## Immunosenescence and immune dysfunction\n## Impact on cancer therapies and ICIs\n## Senolytic and emerging nanotechnology/CAR-T approaches","[{\"question\":\"What is immunosenescence and why does it matter for cancer risk?\",\"answer\":\"Immunosenescence describes age-related deterioration of immune function. This dysfunction reduces effective cancer cell elimination and increases the risk of malignancies.\"},{\"question\":\"Which immune cell types does the review emphasize beyond T cells?\",\"answer\":\"The review focuses on innate immune cells, especially macrophages and neutrophils, whose responses to aging are described as insufficiently covered in prior literature.\"},{\"question\":\"How does immunosenescence affect immune checkpoint inhibitor (ICI) outcomes in elderly patients?\",\"answer\":\"ICIs show broad potential across cancers, but elderly patients often benefit less and may experience immune-related adverse events (irAEs), which the review connects to immunosenescence.\"}]","Immunosenescence promotes cancer development: from mechanisms to treatment strategies | PDF",1790169793,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9e82de35b7221b495f95876dca291c88.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cbc2f60cb34d0025f0024479f2009129.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/17f402b8495fb7673755595dc38afc08.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3d58bc3eeba654f31c56a21a5f69fa61.webp",980,1306]